6-K

TRANSACTION IN OWN SHARES

Company: Indivior Pharmaceuticals, Inc.
Filed: November 5, 2024
Period of Report: November 5, 2024
Accession Number: 0001654954-24-013727

View Document ↗ View on SEC.gov ↗